bis(1,10-phenanthroline)copper(2+) ion

Subscribe to Selected New Research on bis(1,10-phenanthroline)copper(2+) ion

3 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to (Cu+2) cation

Also Known As:

(o-phenanthroline) cupric; Cu(OP)2; Cu(Phen)2; bis(1,10-phenanthroline)copper(2+) ion, diacetate salt; bis(1,10-phenanthroline)copper(2+) ion, diacetate salt, (SP-4-1)-isomer; bis(1,10-phenanthroline)copper(2+) ion, dinitrate; bis(1,10-phenanthroline)copper(2+) ion, diperchlorate; bis(1,10-phenanthroline)copper(2+) ion, sulfate (1:1); cupric di(1,10-phenanthroline)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

3-Ring Heterocyclic Compounds

Phenanthrolines

bis(1,10-phenanthroline)copper(2+) ion: 3

Experts

1.	Devereux, Michael: 1 article (03/2007)
2.	Deegan, Carol: 1 article (03/2007)
3.	McCann, Malachy: 1 article (03/2007)
4.	Coyle, Barry: 1 article (03/2007)
5.	Egan, Denise A: 1 article (03/2007)

Related Diseases

1.	DNA Damage 02/01/2007 - "Oxidative DNA damage was also found in cells treated with Cu(OP)2 in the early stage of the apoptosis, and it suggests that the activation of DNA repair system may be involved in the pathway of the apoptosis induced by Cu(OP)2." 09/08/1993 - "The results are consistent with the following events: (i) the products of menadione metabolism causes copper ion release from some cellular compartment; (ii) in the presence of PHEN, a Cu(PHEN)2 complex is formed; (iii) the Cu(PHEN)2 complex is known to be very clastogenic, inducing DNA damage in a reducing environment" Order ALL the reference details at left...
2.	Carcinoma (Carcinomatosis) 02/01/2007 - "The mechanism of cytotoxicity on liver carcinoma Bel-7402 cells induced by copper-1,10-phenanthroline, Cu(OP)2, has been studied" 03/18/2007 - "The chemotherapeutic potential of 1,10-phenanthroline (phen), and three of its transition metal complexes, namely [Cu(phen)(2)(mal)]x2H(2)O, [Mn(phen)(2)(mal)]x2H(2)O and [Ag(2)(phen)(3)(mal)]x2H(2)O (malH(2)=malonic acid) was determined using two human carcinoma cell lines (A-498 and Hep-G2)" Order ALL the reference details at left...
3.	Neoplasms (Cancer) 03/18/2007 - "In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Vitamin K 3 (Menadione)
2.	Copper
3.	copper-1,10-phenanthroline
4.	malonic acid (malonate)
5.	1,10-phenanthroline

Best Treatments:
Research Summary Report
on DNA Damage

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 425 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>